(Q48251035)

10 February 2018

title

Exposure to oral S-ketamine is unaffected by itraconazole but greatly increased by ticlopidine (English)

1 reference

10 February 2018

author

Miia Turpeinen

5

1 reference

10 February 2018

Pertti J. Neuvonen

7

1 reference

10 February 2018

author name string

M A Peltoniemi

1

1 reference

10 February 2018

T I Saari

2

1 reference

10 February 2018

N M Hagelberg

3

1 reference

10 February 2018

P Reponen

4

1 reference

10 February 2018

K Laine

6

1 reference

10 February 2018

K T Olkkola

8

1 reference

10 February 2018

language of work or name

English

0 references

publication date

29 June 2011

1 reference

10 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

10 February 2018

volume

90

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

296-302

1 reference

10 February 2018

Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

The role of ketamine in pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Use of oral ketamine in chronic pain management: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Metabolism of ketamine stereoisomers by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Effects of enzyme induction, renal and cardiac function on ketamine plasma kinetics in patients with ketamine long-term analgosedation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Inhibition and induction of human cytochrome P450 enzymes: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Ketamine for chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Pharmacokinetics and analgesic effects of i.m. and oral ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

The enzymatic basis of drug-drug interactions with systemic triazole antifungals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Interaction of common azole antifungals with P glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Measurement of Recovery from Outpatient General Anaesthesia with a Simple Ocular Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Pencil and paper tests-sensitivity to psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

Itraconazole increases plasma concentrations of quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

7 January 2021

Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

7 January 2021

Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

7 January 2021

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

7 January 2021

Development of a gas chromatography-mass spectrometry method for determination of ketamine in plasma and its application to human samples.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

7 January 2021

Rapid method for the analysis of itraconazole and hydroxyitraconazole in serum by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

7 January 2021

Rapid and sensitive high performance liquid chromatographic method for the determination of itraconazole and its hydroxy-metabolite in human serum

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

7 January 2021

The use of analogue scales in rating subjective feelings

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.140

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.140

1 reference

10 February 2018

1 reference

10 February 2018